Innoviva Q3 EPS $0.98 May Not Compare To $0.27 Estimate, Sales $67.26M Miss $75.65M Estimate
Portfolio Pulse from Benzinga Newsdesk
Innoviva reported Q3 earnings of $0.98 per share, beating the analyst consensus estimate of $0.27 by 262.96%. However, this is a 65% decrease from the same period last year. The company's quarterly sales of $67.26 million missed the analyst consensus estimate of $75.65 million by 11.09%, but remained the same as last year.
November 01, 2023 | 9:39 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Innoviva's Q3 earnings exceeded estimates but decreased YoY. Sales missed estimates and remained flat YoY.
Innoviva's earnings beat estimates, which is positive. However, the YoY decrease in earnings and missed sales estimates could negatively impact the stock. The net effect could be neutral in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100